- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Results
12
Companies with a Future performance score of at least 3, ordered by Future performance score.
12 companies
Newron Pharmaceuticals
Market Cap: CHF 209.2m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 10.48
7D
-2.1%
1Y
35.2%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 53.80
7D
-6.8%
1Y
-32.1%
Kuros Biosciences
Market Cap: CHF 877.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.72
7D
-2.5%
1Y
22.7%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 62.80
7D
-6.4%
1Y
-17.5%
Sandoz Group
Market Cap: CHF 20.1b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 46.74
7D
-2.0%
1Y
32.7%
Galderma Group
Market Cap: CHF 32.1b
Operates as a dermatology company worldwide.
GALD
CHF 135.40
7D
-6.0%
1Y
69.3%
Lonza Group
Market Cap: CHF 36.7b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 522.20
7D
-3.9%
1Y
-3.0%
PolyPeptide Group
Market Cap: CHF 781.9m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 23.70
7D
-7.8%
1Y
-25.4%
Tecan Group
Market Cap: CHF 1.8b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 145.60
7D
-7.9%
1Y
-48.8%
Bachem Holding
Market Cap: CHF 4.3b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 57.70
7D
-12.6%
1Y
-20.9%
Roche Holding
Market Cap: CHF 217.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 253.50
7D
-4.4%
1Y
-6.9%
Siegfried Holding
Market Cap: CHF 3.4b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 78.20
7D
-7.0%
1Y
-32.0%